-
Security Type
-
Convertible Note
-
Min Investment
-
$1,000
-
Offering Date
-
May 20, 2021
-
Expected Close Date
-
November 30, 2021
-
Target Raise
-
$50.00K-$124.00K
-
Security Price
-
$1
Company Description
With Clear Protocol, doctors and nurses on their rounds can easily validate clinical procedures, hands-free. Patient records are updated automatically.
Key Deal Facts
A necessity for Covid-19 treatments. Voice operated, hands-free: removes the burden of data entry.
Artificial Intelligence-powered. Software-as-a-Service. (SaaS). Scalable - Efficient Use of Capital.
Every nurse and doctor in the country is a potential user of the Clear Protocol® system.
Validation of clinical protocols will save thousands of lives by avoiding preventable errors.Recurring Business-to-Business revenue, in healthcare with predictable, growing demand.Expert advisory board, includes faculty from leading universities, distinguished doctors, attorneys.
Reduces malpractice liability. Helps reduce hospital costs.US Utility Patent 10,318,928B1. Additional patents pending. Registered US Trademark.
Management Team / Advisory Board Bios
Ernest Kestone, CEO & Co-Founder
Co-inventor, clinical validation system, can help save hundreds of thousands of lives every year.
Seanna Thompson, MD
Senior Medical Director, Clinical Network Development Mount Sinai. Certified Physician Executive. Keynote Speaker. Healthcare Innovation.
Dimitrios Zikos, PhDAssistant Professor at Central Michigan University. He has graduated from the faculty of Nursing, University of Athens and was awarded a Ph.D. title in Health Informatics in 2009.